Epidemiological studies suggest that dietary fat may be involved in the aetiology of certain cancers (Armstrong and Doll, 1975; Nicholson et al., 1988) . In animal studies, the level of dietary fat intake influences chemically induced mammary tumour initiation/promotion and the metastatic behaviour of the tumour. Some studies have shown that diets rich in n-6 polyunsaturated fatty acids (PUFAs) (e.g. corn oil, sunflower seed oil) stimulate tumour growth and development (Hillyard and Abraham, 1979; Cave, 1991; Reddy et al., 1991) . In contrast, the n-3 fatty acids (FAs) (e.g. fish oil), mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), frequently inhibit growth of carcinogen-induced tumours (Cohen et al., 1986; Minoura et al., 1988; Karmali et al., 1989a; O'Connor et al., 1989; Takata et al., 1990; Locniscar et al., 1991; Reddy et al., 1991; Cohen et al., 1993) . Diets rich in EPA and DHA inhibit the growth of transplantable tumours in nude mice (Karmali et al., 1984 (Karmali et al., , 1987 Gabor and Abraham, 1986; Kort et al., 1987; Rose and Cohen, 1988; Canizzo and Broitman, 1989; Sacaguchi et al., 1990; Bravo et al., 1991) . The inhibition of cell proliferation when the growth medium is supplemented with n-3 FAs has been well documented (Chow et al., 1989; Rose and Connolly, 1991; H0stmark and Lystad, 1992) , but the molecular changes that n-3 FAs induce in the cells and variation in sensitivity to n-3 FAs remain poorly understood.. Effects of n-3 FAs are seen on the invasiveness of malignant murine melanoma cells and human fibrosarcoma cells in cell culture systems (Reich et al., 1989) . A reduced ability to metastasise experimentally has been shown in malignant murine melanomas, colon carcinoma cells and mammary adenocarcinoma cell lines (Canizzo and Broitman, 1989; Reich et al., 1989; Adams et al., 1990) . Several cell lines resistant to cytostatic drugs are sensitised by n-3 FA treatment in culture (Burns and North, 1986; Zulstra et al., 1987; TimmerBosscha et al., 1989; Burns et al., 1993; Krokan et al., 1993) . However, some resistant cell lines are not sensitised at all (Krokan et al., 1993) , and for some n-3-sensitive cell lines the effect of combination of polyunsaturated fatty acids and cytotoxic drugs is merely additive (Plumb et al., 1993) . Nevertheless, these results are very promising in relation to treatment of human cancers. And in experimental models an anticachectic effect occurs when a diet with n-3 triglycerides is given to mice with certain tumours (Tisdale and Dhesi, 1990 by incubation in trichloroacetic acid (TCA) (5%, w/v) for 10 min at 4°C. The wells were then washed three times in water and the cell monolayers were lysed in 0.5% sodium dodecyl sulphate (SDS), 0.25 M sodium hydroxide at 60'C for 30 min and radioactivity measured by liquid scintillation counting.
Animalfeeding
The mice were fed a basal mixture supplemented with either com oil (11% of the weight) or 6% or 8% K85 (a mixture of n-3 ethyl esters of FAs). The total amount of fat was the same in the experimental and the control groups (Table I) .
Balb/cA (Bom) female athymic nude mice (5 weeks of age) were housed in filter top-cages in a pathogen-free laminar air flow chamber at 26°C. The different diets were prepared, immediately packed in plastic bags, flushed with nitrogen and stored at -25°C. The mice were given the diet ad libitum every day. Remaining food was removed the next morning. The light/dark cycle was 12 h and relative humidity was above 55% relative humidity.
After 2 weeks feeding on either n-3 FA ethyl esters K85 or corn oil, 0.1 ml of HBS containing 5 x 106 cells was injected s.c. All animals were monitored daily for tumour growth and weighed weekly. Tumour volume was measured with calipers using the formula: a x a x b/2 (where a is the shortest and b is the longest measured diameter). The feeding experiments were continued until some of the tumours reached a defined limit of approximately 2 x 2 cm. The THKE tumour experiment was terminated 90 days and the A427 tumour experiment 99 days after cell inoculation. Tumours were removed and processed for lipid analysis and histopathological evaluation. Tissue sections were stained with haematoxylin and eosin. As shown in Figure 1 , acquisition of the tumorigenic phenotype increases the sensitivity of the cell line to n-3 FAs compared with IHKE cells. The growth of THKE cells was inhibited 25% more than the growth of IHKE cells at 80 giM EPA (P<0.01) and 35% more at 40pM DHA (P<0.001).
For comparison, we then determined the 50% inhibitory doses for a human tumour cell line that we had previously found is highly sensitive to n-3 FAs (A427) and for normal human fibroblasts, which have been found to be resis-tant (Krokan et al., 1993) . The apparent 50% inhibitory dose for A427 was between 5 and 10 YM for all FAs (Figure 3) . A thymidine incorporation experiment gave similar results as the cell proliferation study (data not shown). Fifty per cent inhibition of the human fibroblast cell line was not obtained within the concentration range tested (Figure 3 ).
In vivo experiments None of the treatments used in the present study had any effect on survival of the mice or on the tumour take rate in any of the groups. Likewise, body weight data showed little difference within the two groups (Figure 4) . This is in agreement with the lack of toxic effect observed in normal human fibroblasts in vitro (Figure 3 ). However, a limited toxic effect on some human cell types cannot be excluded.
The effect of K85 was tested on THKE and A427 cell growth in vivo after implantation into the mice. For both cell lines tested, tumour size at the end of the experiments was smaller in K85-fed animals than in animals receiving a control diet (Figures 5 and 6) FA measurements The FA contents of the tumours are shown in Table II . Tumours in the K85-fed animals have a significant higher level of n-3 FAs (EPA and DHA). In addition, ARA was significantly lowered after K85 in the THKE tumours, whereas LA was significantly lowered in A427 tumours. Table II shows a shift from <0.1 to 3.1 (EPA) and from 1.4 to 5.4 (DHA) in the THKE tumours and a shift from <0.1 to 2.6 (EPA) and from 0.3 to 4.5 (DHA) for A427 cells. (Reddy and Maeura, 1984; Reddy et al., 1991) . One of the objectives of this study was to investigate changes in cellular sensitivity to FAs during neoplastic progression in vitro. Immortalisation plays a critical role in carcinogenesis. Studies indicate that both oncogenes and tumour-suppressor genes are involved in the immortalisation process (Shay et al., 1991) . We have developed an in vitro et al., 1989 Distel et al., 1992) . Our results therefore indicate that the changed n-3 FA effect was a late event during the progression to malignancy. DNA sequence analysis of IHKE cells has revealed a mutation in the p53 gene (Mvhle et al., 1992) .
The mutated form of p53 may inhibit the antiproliferative effect of FAs by interfering with its signalling pathway. Our results are consistent with the effect of FAs in other systems, but are in contrast to other in vitro studies in which n-3 FAs were shown to be cytotoxic to tumorigenic cells while normal cells were not killed (Begin et al., 1986; Das, 1991; Rose and Connolly, 1991) . However, the differences between NI4KE
cells and transformed cells may be a result of less than optimal culture conditions for the NHKE cells. In addition, NHKE cells have less growth potential than transformed cells and may therefore be more easily perturbed after in vitro treatments. We have found that reduced concentration of FCS in the cell culture medium increases the toxicity of the FAs to the kidney epithelial cells (data not shown). The higher toxicity of FAs at lower FCS concentration may be due to a protective effect of albumin (Lystad et al., 1994) . Previous studies have shown that there is a wide variation in cellular sensitivity to FAs (Krokan et al., 1993) . We found A427 to be extremely sensitive to FAs, while IHKE and THKE cells and human fibroblasts were more resistant to FAs. The mechanism by which n-3 FAs affect cell proliferation is not yet clear. Gonzales (1990) proposed the hypothesis that fish oils can inhibit mammary gland tumorigenesis by increasing the level of peroxidation products. Previous studies with IHKE cells have demonstrated that growth inhibition in vitro by FAs increases with increasing number of double bonds (Lystad et al., 1994) , and there is a relationship between the suppressive effect on cell proliferation and thiobarbituric acid-reactive substances (TBARS) in the culture medium. It therefore seems that the production of lipid peroxidation products may be an important cause of cell toxicity in these cells. The agents responsible for this toxicity may be highly toxic hydroxyalkenals (Esterbauer et al., 1988) . The cells' capacity to detoxify these aldehydes may be an important determinant. However, other mechanisms by which FAs may influence growth may be operating. A significant reduction in the formation of growth-stimulatory eicosanoids such as prostaglandin E2 and leukotrienes by n-3 FAs has been observed (Abou-El-Ela et Karmali et al., 1989b) . Recently, it was proposed that FAs can modulate gene expression (Tiwari et al., 1991; Distel et al., 1992) .
Previous studies have shown n-3 FAs to be effective inhibitors of growth of a transplantable rat mammary carcinoma and of human breast and prostate cancer cells in athymic nude mice fed fish oil rich in EPA and DHA (Rose and Connolly, 1991; Welsch, 1992) . In the present study the in vitro inhibition by FAs is consistent with the in vivo sensitivity when nude mice were fed K85 (55% EPA and 30% DHA). In the in vivo experiments DHA and EPA are added to the diet as ethylesters, while corn oil added in the control diet is in its natural triacylglycerol form. However, the bioavailability of DHA and EPA as ethylesters and triacylglycerol has been previously shown to be equal (Krokan et al., 1993b) . Therefore it is reasonable to compare the effect of the two different chemical forms of FAs in the same experiment. In the K85 fed animals both tumour types incorporated large amounts of n-3 FAs, replacing in part n-6 FAs. The magnitude of the change in the n-3 composition of the phospholipids of the resistant cell line did not seem to be strikingly different from that in the sensitive cell line. However, in the nude mice fed corn oil we observed a significantly lower incorporation of DHA in A427 tumours. Furthermore, 20:4, n-6 was reduced by some 50% in the THKE cells after K85 treatment. If prostanoids derived from 20:4, n-6 are important for the growth of this cell line, then the reduction in 20:4, n-6 may explain this growth reduction. The present study confirms that EPA and DHA reduce the level of ARA, resulting in a decrease in the 2-series of prostaglandin synthesis. The magnitude of incorporation of ARA in the A427 tumour fed corn oil was lower than in the THKE tumour. This lower incorporation of ARA was in the A427 cell line counterbalanced by LA. K85 did not change the incorporation of LA in the THKE tumour phospholipids.
It is concluded from these findings that acquisition of the tumorigenic phenotype influenced the cellular sensitivity to FAs. Further, the in vitro effect of FAs correlated with the effect on tumour growth in nude mice. Further studies are needed to understand the complexity of dietary lipid effects during the stepwise progression to malignant cells. Relating the diverse and cell-specific biological effects of FAs to molecular mechanisms will help in understanding of the role of dietary fat in human cancer.
